No Data
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
Baird Maintains Applied Therapeutics(APLT.US) With Buy Rating, Maintains Target Price $14
Applied Therapeutics Shares Are Trading Higher After Leerink Partners and Citigroup Raised Their Respective Price Targets on the Stock.
Applied Therapeutics Is Maintained at Outperform by Leerink Partners
Applied Therapeutics Analyst Ratings
Steelcase Reports Weak Sales, Joins American Healthcare REIT And Other Big Stocks Moving Lower In Thursday's Pre-Market Session